672
Views
11
CrossRef citations to date
0
Altmetric
Review

Community-acquired bacterial pneumonia in adult HIV-infected patients

, , , &
Pages 579-588 | Received 28 Jan 2018, Accepted 26 Jun 2018, Published online: 12 Jul 2018

References

  • WHO | World Health Statistics 2016: Monitoring health for the SDGs [Internet]. WHO. [cited 2017 Dec 19]. Available from: http://www.who.int/gho/publications/world_health_statistics/2016/en/
  • Brown J, Community-Acquired LM. Pneumonia in HIV-Infected Individuals. Curr Infect Dis Rep. 2014 Mar;16(3):397.
  • Feldman C, Anderson R, Rossouw T. HIV-related pneumococcal disease prevention in adults. Expert Rev Respir Med. 2017 Mar;11(3):181–199.
  • Cilloniz C, Torres A, Polverino E, et al. Community-acquired lung respiratory infections in HIV-infected patients: microbial aetiology and outcome. Eur Respir J. 2014 Jun;43(6):1698–1708.
  • Cillóniz C, Torres A, Manzardo C, et al. Community-acquired pneumococcal pneumonia in virologically suppressed HIV-infected adult patients: a matched case-control study. Chest. 2017;152(2):295–303. ug.
  • Feldman C, Anderson R. HIV-associated bacterial pneumonia. Clin Chest Med. 2013 Jun;34(2):205–216.
  • Søgaard OS, Reekie J, Ristola M, et al. Severe bacterial non-aids infections in HIV-positive persons: incidence rates and risk factors. J Infect. 2013 May;66(5):439–446.
  • Feikin DR, Feldman C, Schuchat A, et al. Global strategies to prevent bacterial pneumonia in adults with HIV disease. Lancet Infect Dis. 2004 Jul;4(7):445–455.
  • Malinis M, Myers J, Bordon J, et al. Clinical outcomes of HIV-infected patients hospitalized with bacterial community-acquired pneumonia. Int J Infect Dis IJID Off Publ Int Soc Infect Dis. 2010 Jan;14(1):e22–27.
  • Christensen D, Feldman C, Rossi P, et al. HIV infection does not influence clinical outcomes in hospitalized patients with bacterial community-acquired pneumonia: results from the CAPO international cohort study. Clin Infect Dis Off Publ Infect Dis Soc Am. 2005 Aug 15;41(4):554–556.
  • The top 10 causes of death [Internet]. World Health Organization. [ cited 2018 Apr 26]. Available from: http://www.who.int/news-room/fact-sheets/detail/the-top-10-causes-of-death
  • Sogaard OS, Lohse N, Gerstoft J, et al. Hospitalization for pneumonia among individuals with and without HIV infection, 1995–2007: a Danish population-based, nationwide cohort study. Clin Infect Dis Off Publ Infect Dis Soc Am. 2008 Nov 15;47(10):1345–1353.
  • Grau I, Pallares R, Tubau F, et al. Epidemiologic changes in bacteremic pneumococcal disease in patients with human immunodeficiency virus in the era of highly active antiretroviral therapy. Arch Intern Med. 2005 Jul 11;165(13):1533–1540.
  • Gordin FM, Roediger MP, Girard P-M, et al. Pneumonia in HIV-infected persons: increased risk with cigarette smoking and treatment interruption. Am J Respir Crit Care Med. 2008 Sep 15;178(6):630–636.
  • Feldman C, Klugman KP, Yu VL, et al. Bacteraemic pneumococcal pneumonia: impact of HIV on clinical presentation and outcome. J Infect. 2007 Aug;55(2):125–135.
  • Lamas CC, Coelho LE, Grinsztejn BJ, et al. Community-acquired lower respiratory tract infections in HIV-infected patients on antiretroviral therapy: predictors in a contemporary cohort study. Infection. 2017 Dec;45(6):801–809.
  • Kunisaki KM. Will expanded ART use reduce the burden of HIV-associated chronic lung disease? Curr Opin HIV AIDS. 2014 Jan;9(1):27–33.
  • Crothers K, Huang L, Goulet JL, et al. HIV infection and risk for incident pulmonary diseases in the combination antiretroviral therapy era. Am J Respir Crit Care Med. 2011 Feb 1;183(3):388–395.
  • Madeddu G, Porqueddu EM, Cambosu F, et al. Bacterial community acquired pneumonia in HIV-infected inpatients in the highly active antiretroviral therapy era. Infection. 2008 Jun;36(3):231–236.
  • Mussini C, Galli L, Lepri AC, et al. Incidence, timing, and determinants of bacterial pneumonia among HIV-infected patients: data from the ICONA Foundation Cohort. J Acquir Immune Defic Syndr 1999. 2013 Jul 1;63(3):339–345.
  • O’Connor J, Vjecha MJ, Phillips AN, et al. Effect of immediate initiation of antiretroviral therapy on risk of severe bacterial infections in HIV-positive people with CD4 cell counts of more than 500 cells per μL: secondary outcome results from a randomised controlled trial. Lancet HIV. 2017 Mar;4(3):e105–12.
  • Almirall J, Bolíbar I, Serra-Prat M, Roig J, Hospital I, Carandell E, et al. New evidence of risk factors for community-acquired pneumonia: a population-based study. Eur Respir J. 2008 Jun;31(6):1274–1284.
  • Torres A, Peetermans WE, Viegi G, et al. Risk factors for community-acquired pneumonia in adults in Europe: a literature review. Thorax. 2013 Nov;68(11):1057–1065.
  • Bénard A, Mercié P, Alioum A, et al. Bacterial pneumonia among HIV-infected patients: decreased risk after tobacco smoking cessation. ANRS CO3 Aquitaine Cohort 2000–2007 PloS One. 2010 Jan 26;5(1):e8896.
  • Mdodo R, Frazier EL, Dube SR, et al. Cigarette smoking prevalence among adults with HIV compared with the general adult population in the United States: cross-sectional surveys. Ann Intern Med. 2015 Mar 3;162(5):335–344.
  • Frazier EL, Sutton MY, Brooks JT, et al. Trends in cigarette smoking among adults with HIV compared with the general adult population, United States – 2009–2014. Prev Med. 2018 Mar 14;111:231–234.
  • Prejean J, Song R, Hernandez A, et al. Estimated HIV incidence in the United States, 2006–2009. PloS One. 2011;6(8):e17502.
  • Yanagi S, Tsubouchi H, Miura A, et al. The impacts of cellular senescence in elderly pneumonia and in age-related lung diseases that increase the risk of respiratory infections. Int J Mol Sci. 2017 Feb 25;18:3.
  • Almirall J, Serra-Prat M, Bolíbar I, et al. Passive smoking at home is a risk factor for community-acquired pneumonia in older adults: a population-based case-control study. BMJ Open. 2014 Jun 13;4(6):e005133.
  • Chinnapaiyan S, Unwalla HJ. Mucociliary dysfunction in HIV and smoked substance abuse. Front Microbiol. 2015;6:1052.
  • Feldman JG, Minkoff H, Schneider MF, et al. Association of cigarette smoking with HIV prognosis among women in the HAART era: a report from the women’s interagency HIV study. Am J Public Health. 2006 Jun;96(6):1060–1065.
  • Yuan Y, L’italien G, Mukherjee J, et al. Determinants of discontinuation of initial highly active antiretroviral therapy regimens in a US HIV-infected patient cohort. HIV Med. 2006 Apr;7(3):156–162.
  • Pacek LR, Crum RMA. Review of the literature concerning HIV and cigarette smoking: morbidity and mortality, associations with individual- and social-level characteristics, and smoking cessation efforts. Addict Res Theory. 2015 Feb;23(1):10–23.
  • Reynolds NR. Cigarette smoking and HIV: more evidence for action. AIDS Educ Prev Off Publ Int Soc AIDS Educ. 2009 Jun;21(3 Suppl):106–121.
  • Hile SJ, Feldman MB, Alexy ER, et al. Recent tobacco smoking is associated with poor HIV medical outcomes among HIV-infected individuals in New York. AIDS Behav. 2016 Aug;20(8):1722–1729.
  • Lalloo UG, Pillay S, Mngqibisa R, et al. HIV and COPD: a conspiracy of risk factors. Respirol Carlton Vic. 2016 Oct;21(7):1166–1172.
  • Makinson A, Hayot M, Eymard-Duvernay S, et al. HIV is associated with airway obstruction: a matched controlled study. AIDS. 2018 Jan 14;32(2):227–232.
  • Raju R, Peters BS, Breen RAM. Lung infections in the HIV-infected adult. Curr Opin Pulm Med. 2012 May;18(3):253–258.
  • Figueiredo-Mello C, Naucler P, Negra MD, et al. Prospective etiological investigation of community-acquired pulmonary infections in hospitalized people living with HIV. Medicine (Baltimore). 2017 Jan;96(4):e5778.
  • Boyles TH, Brink A, Calligaro GL, et al. South African guideline for the management of community-acquired pneumonia in adults. J Thorac Dis. 2017 Jun;9(6):1469–1502.
  • Perelló R, Miró O, Marcos MA, et al. Predicting bacteremic pneumonia in HIV-1-infected patients consulting the ED. Am J Emerg Med. 2010 May;28(4):454–459.
  • Albrich WC, Madhi SA, Adrian PV, et al. Pneumococcal colonisation density: a new marker for disease severity in HIV-infected adults with pneumonia. BMJ Open. 2014;4(8):e005953.
  • Albrich WC, Madhi SA, Adrian PV, et al. Use of a rapid test of pneumococcal colonization density to diagnose pneumococcal pneumonia. Clin Infect Dis Off Publ Infect Dis Soc Am. 2012 Mar 1;54(5):601–609.
  • Benito N, Moreno A, Miro JM, et al. Pulmonary infections in HIV-infected patients: an update in the 21st century. Eur Respir J. 2012 Mar 1;39(3):730–745.
  • Head BM, Trajtman A, Rueda ZV, et al. Atypical bacterial pneumonia in the HIV-infected population. Pneumonia Nathan Qld. 2017;9:12.
  • Robbins NM, Kumar A, Blair BM. Legionella pneumophila infection presenting as headache, confusion and dysarthria in a human immunodeficiency virus-1 (HIV-1) positive patient: case report. BMC Infect Dis. 2012 Sep 22;12:225.
  • Franzin L, Dal Conte I, Cabodi D, et al. Culture proven Legionella pneumophila pneumonia in a HIV-infected patient: case report and review. J Infect. 2002 Oct;45(3):199–201.
  • Sandkovsky U, Sandkovsky G, Suh J, et al. Legionella pneumonia and HIV: case reports and review of the literature. AIDS Patient Care STDs. 2008 Jun;22(6):473–481.
  • Cillóniz C, Miguel-Escuder L, Pedro-Bonet ML, et al. Community-acquired legionella pneumonia in HIV-Infected adult patients: a matched case-control study. Clin Infect Dis Off Publ Infect Dis Soc Am. 2018 Apr;12. doi: org/10.1093/cid/ciy314
  • Boschini A, Smacchia C, Di FM, et al. Community-acquired pneumonia in a cohort of former injection drug users with and without human immunodeficiency virus infection: incidence, etiologies, and clinical aspects. Clin Infect Dis Off Publ Infect Dis Soc Am. 1996 Jul;23(1):107–113.
  • Sheth AN, Althoff KN, Brooks JT. Influenza susceptibility, severity, and shedding in HIV-infected adults: a review of the literature. Clin Infect Dis Off Publ Infect Dis Soc Am. 2011 Jan 15;52(2):219–227.
  • Cohen C, Simonsen L, Sample J, et al. Influenza-related mortality among adults aged 25–54 years with AIDS in South Africa and the United States of America. Clin Infect Dis Off Publ Infect Dis Soc Am. 2012 Oct;55(7):996–1003.
  • Ormsby CE, De La Rosa-Zamboni D, Vázquez-Pérez J, et al. Severe 2009 pandemic influenza A (H1N1) infection and increased mortality in patients with late and advanced HIV disease. AIDS Lond Engl. 2011 Feb 20;25(4):435–439.
  • Martínez E, Marcos MA, Hoyo-Ulloa I, et al. Influenza A H1N1 in HIV-infected adults. HIV Med. 2011 Apr;12(4):236–245.
  • Shenoy MK, Iwai S, Lin DL, et al. Immune response and mortality risk relate to distinct lung microbiomes in patients with HIV and Pneumonia. Am J Respir Crit Care Med. 2017 Jan 1;195(1):104–114.
  • Cribbs SK, Uppal K, Li S, et al. Correlation of the lung microbiota with metabolic profiles in bronchoalveolar lavage fluid in HIV infection. Microbiome. 2016 Jan;20(4):3.
  • Iwai S, Fei M, Huang D, et al. Oral and airway microbiota in HIV-infected pneumonia patients. J Clin Microbiol. 2012 Sep;50(9):2995–3002.
  • Fine MJ, Auble TE, Yealy DM, Hanusa BH, Weissfeld LA, Singer DE, et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med. 1997 Jan 23;336(4):243–250.
  • Lim WS, Van Der Eerden MM, Laing R, et al. Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax. 2003 May;58(5):377–382.
  • Mandell LA, Wunderink RG, Anzueto A, et al. Infectious diseases society of America/American thoracic society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis Off Publ Infect Dis Soc Am. 2007 Mar 1;44(Suppl 2):S27–72.
  • Curran A, Falcó V, Crespo M, et al. Bacterial pneumonia in HIV-infected patients: use of the pneumonia severity index and impact of current management on incidence, aetiology and outcome. HIV Med. 2008 Oct;9(8):609–615.
  • Almeida A, Almeida AR, Castelo Branco S, et al. and other markers of illness severity in community-acquired pneumonia among HIV-positive patients. Int J STD AIDS. 2016 Oct;27(11):998–1004.
  • Lim WS, Baudouin SV, George RC, et al. BTS guidelines for the management of community acquired pneumonia in adults: update 2009. Thorax. 2009 Oct;64(Suppl 3):iii1–55.
  • Figueiredo-Mello C, Naucler P, Negra MD, et al. Ceftriaxone versus ceftriaxone plus a macrolide for community-acquired pneumonia in hospitalized patients with HIV/AIDS: a randomized controlled trial. Clin Microbiol Infect Off Publ Eur Soc Clin Microbiol Infect Dis. 2018 Feb;24(2):146–151.
  • Baddour LM, Yu VL, Klugman KP, et al. Combination antibiotic therapy lowers mortality among severely ill patients with pneumococcal bacteremia. Am J Respir Crit Care Med. 2004 Aug 15;170(4):440–444.
  • Mkoko P, Raine RI. HIV-positive patients in the intensive care unit: a retrospective audit. South Afr Med J Suid-Afr Tydskr Vir Geneeskd. 2017 Sep 22;107(10):877–881.
  • Bordon J, Kapoor R, Martinez C, et al. CD4+ cell counts and HIV-RNA levels do not predict outcomes of community-acquired pneumonia in hospitalized HIV-infected patients. Int J Infect Dis IJID Off Publ Int Soc Infect Dis. 2011 Dec;15(12):e822–827.
  • Mayaud C, Parrot A, Cadranel J. Pyogenic bacterial lower respiratory tract infection in human immunodeficiency virus-infected patients. Eur Respir J Suppl. 2002 Jul;36:28s–39s.
  • Heffernan RT, Barrett NL, Gallagher KM, et al. Declining incidence of invasive Streptococcus pneumoniae infections among persons with AIDS in an era of highly active antiretroviral therapy, 1995–2000. J Infect Dis. 2005 Jun 15;191(12):2038–2045.
  • Barakat LA, Juthani-Mehta M, Allore H, et al. Comparing clinical outcomes in HIV-infected and uninfected older men hospitalized with community-acquired pneumonia. HIV Med. 2015 Aug;16(7):421–430.
  • Justice AC, Modur SP, Tate JP, et al. Predictive accuracy of the veterans aging cohort study index for mortality with HIV infection: a North American cross cohort analysis. J Acquir Immune Defic Syndr 1999. 2013 Feb 1;62(2):149–163.
  • Akgün KM, Tate JP, Pisani M, et al. Medical ICU admission diagnoses and outcomes in human immunodeficiency virus-infected and virus-uninfected veterans in the combination antiretroviral era. Crit Care Med. 2013 Jun;41(6):1458–1467.
  • Pulmonary Complications of HIV [Internet]. European Respiratory Society; 2014. 277 p. [cited 2018 Jan 1]. Available from: http://books.ersjournals.com/content/9781849840552/9781849840552
  • Geretti AM, Brook G, Cameron C, et al. British HIV association guidelines on the use of vaccines in HIV-positive adults 2015. HIV Med. 2016 Aug;17(Suppl 3):s2–81.
  • EACS Guidelines [Internet]. [ cited 2017 Dec 11]. Available from: http://www.eacsociety.org/guidelines/eacs-guidelines/eacs-guidelines.html
  • Frésard A, Gagneux-Brunon A, Lucht F, et al. Immunization of HIV-infected adult patients - French recommendations. Hum Vaccines Immunother. 2016;12(11):2729–2741.
  • Kim DK, Riley LE, Harriman KH, et al. Advisory committee on immunization practices. recommended immunization schedule for adults aged 19 years or older, United States, 2017. Ann Intern Med. 2017 Feb 7;166(3):209–219.
  • Rubin LG, Levin MJ, Ljungman P, et al. 2013 IDSA clinical practice guideline for vaccination of the immunocompromised host. Clin Infect Dis Off Publ Infect Dis Soc Am. 2014 Feb;58(3):309–318.
  • Aberg JA, Gallant JE, Ghanem KG, et al. Primary care guidelines for the management of persons infected with HIV: 2013 update by the HIV medicine association of the infectious diseases society of America. Clin Infect Dis Off Publ Infect Dis Soc Am. 2014 Jan;58(1):1–10.
  • Centers for Disease Control and Prevention (CDC). Use of. 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine for adults with immunocompromising conditions: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep. 2012 Oct 12;61(40):816–819.
  • Sadlier C, O’Dea S, Bennett K, et al. Immunological efficacy of pneumococcal vaccine strategies in HIV-infected adults: a randomized clinical trial. Sci Rep. 2016 Sep;1(6):32076.
  • Crum-Cianflone NF, Sullivan E. Vaccinations for the HIV-infected adult: a review of the current recommendations, Part I. Infect Dis Ther. 2017 Sep;6(3):303–331.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.